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NEPTUNE are detailed in Supplemental Acknowledgments.

To define cellular mechanisms underlying kidney function and failure, the KPMP analyzes biopsy
tissue in a multicenter research network to build cell-level process maps of the kidney. This study
aimed to establish a single cell RNA sequencing strategy to use cell-level transcriptional profiles
from kidney biopsies in KPMP to define molecular subtypes in glomerular diseases. Using multiple
sources of adult human kidney reference tissue samples, 22,268 single cell profiles passed
KPMP quality control parameters. Unbiased clustering resulted in 31 distinct cell clusters that
were linked to kidney and immune cell types using specific cell markers. Focusing on endothelial
cell phenotypes, in silico and in situ hybridization methods assigned 3 discrete endothelial cell
clusters to distinct renal vascular beds. Transcripts defining glomerular endothelial cells (GEC) were
evaluated in biopsies from patients with 10 different glomerular diseases in the NEPTUNE and
European Renal cDNA Bank (ERCB) cohort studies. Highest GEC scores were observed in patients
with focal segmental glomerulosclerosis (FSGS). Molecular endothelial signatures suggested 2
distinct FSGS patient subgroups with α-2 macroglobulin (A2M) as a key downstream mediator of
the endothelial cell phenotype. Finally, glomerular A2M transcript levels associated with lower
proteinuria remission rates, linking endothelial function with long-term outcome in FSGS.

Introduction
The complexity of kidney structure and function make understanding the mechanisms responsible for
kidney disease development and progression challenging. Genome-wide bulk mRNA profiles of kidney
tissues provide a starting point to map the molecular underpinning of disease pathogenesis and progression. Successes of this approach include the identification of noninvasive biomarkers from tissue gene
expression studies of acute kidney injury (1), chronic kidney disease (2), and targets for potentially novel
therapeutic approaches (3, 4). However, bulk mRNA gene expression measurements reflect an average
across all captured cell types rather than focusing on cell-specific transcriptional responses. Analytical
approaches to identify the most likely cellular source of transcriptional profiles have been used to overcome this limitation (5–7). While these methods have improved our understanding of cellular contribution to bulk mRNA expression profiles, they do not fully capture the transcriptional programs of individual cells. In recent years, RNA sequencing approaches at the single cell transcriptome level (scRNAseq)
have been developed and are being refined specifically for kidney tissue (8, 9). scRNAseq allows the measurement and comparison of comprehensive gene sets obtained from individual cells and, thus, enables
the capture of previously underappreciated cellular heterogeneity within kidney tissue in health and disease. For example, scRNAseq studies (10–14) have provided comprehensive and dynamic gene expression
profiles of the human developing kidney and human organoids at the single cell level (10, 12) and have
identified resident immune phenotypes in kidney tissues in lupus nephritis (15).

insight.jci.org   https://doi.org/10.1172/jci.insight.133267
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Figure 1. Analysis workflow showing the generation of adult kidney single cell clusters. Combined processing of 24 samples including 16 tumor-nephrectomy, 5
surveillance, and 3 preperfusion biopsies using the scRNAseq protocol yielded 22,268 cells (4690 from surveillance biopsies; 14,744 from tumor-nephrectomies;
and 2834 cells from preperfusion biopsies) and resulted in 31 distinct clusters. Seurat R package was used for the unsupervised clustering of the single cell data.

The KPMP has been created with a goal to change the way we understand and treat kidney disease. KPMP
has identified access to human biopsy tissue as a critical first step in defining disease heterogeneity and determining the precise molecular pathways driving kidney disease. Tissue from a kidney biopsy can provide the
opportunity for a variety of molecular analyses of diseases embedded in both the structural organ context and
the clinical phenotype (16). Despite collaborative success in collecting biopsy tissue, generating single cell data
from adult human nephrons, with their highly differentiated epithelial and endothelial subtypes, has proven
particularly challenging due to the rapid decline in cell viability upon dissociation (17). Recently, first cell/
nucleus analyses of normal adult human kidneys have been published (9, 18, 19). However, a comprehensive
map of single cell types from multiple normal human kidney sources such as nontumor sections of tumornephrectomies, surveillance, and preperfusion biopsies is yet to be developed. Such a reference map for the
adult human kidney will provide insights into human disease and is critical as a comparator for biopsy-driven single cell studies aiming to identify underlying targetable mechanisms for early detection and treatment.
An overall strategy was developed to address 3 main goals presented in this study: (a) to establish a protocol for
kidney biopsy–based scRNAseq analysis capturing all cellular elements of the kidney (Figure 1); (b) to establish a
map of the transcripts found in kidney cell types defined by data-driven clustering; and (c) to test the ability of this
technique to identify distinct, cell type–specific features seen in bulk RNA profiling from human kidney disease as
a means to understand and identify key cellular mechanisms underlying kidney disease phenotypes (Figure 2).

Results
KPMP scRNAseq protocol for analysis of adult human kidney. Intrinsic nephron cell types and tissue-resident
immune cells were recovered from kidney biopsy specimens using a scRNAseq protocol for KPMP, designed
insight.jci.org   https://doi.org/10.1172/jci.insight.133267
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Figure 2. Analysis workflow showing the integration of single cell with bulk mRNAseq data. The glomerular endothelial-specific transcripts identified
from scRNAseq analyses were used to identify distinct subgroups within FSGS using mRNAseq profiles available from NEPTUNE.

for deployment in a multicenter research network (kpmp.org). Twenty-four adult, nondiseased, human kidney tissue samples were processed using the KPMP scRNAseq protocol, including 16 unaffected specimens
from tumor-nephrectomies, 3 preperfusion living donor kidney biopsies, and 5 surveillance kidney transplant biopsies. The combined samples yielded 22,268 cells (4690 from surveillance biopsies, 14,744 from
tumor-nephrectomies, and 2834 cells from preperfusion biopsies) that passed the KPMP quality control
parameters. Unsupervised clustering of all 22,268 cells resulted in 31 distinct clusters, ranging in size from
1412 cells to 58 cells (Figure 3A and Table 1). The scRNAseq expression data set has been loaded into the
scRNAseq viewer Nephrocell and can be explored at Nephrocell.MiKTMC.org.
Identification of kidney cell types. Differential expression analysis of the genes expressed in each cluster versus all other clusters generated cell type–specific gene sets (FDR < 0.05) (Supplemental Table 1; supplemental material available online with this article; https://doi.org/10.1172/jci.insight.133267DS1). Each gene set
included known kidney cell type–specific markers, which enabled assignment of clusters to specific cell types.
Once cluster identities were established, the gene sets provided potentially novel cell type–specific markers.
Figure 3B indicates the cluster (or cell type) specificity of the most differentially expressed genes in each cluster.
Each cluster included cells from all 3 different sample sources used, supporting comparable cellular
yields from each source and the absence of sample-specific batch effects (Figure 4). Distribution of cells
from all 24 samples in the 31 clusters are listed in Supplemental Table 2. Alignment of cell clusters with
kidney cell types (20) using known cell type markers are outlined in Supplemental Table 1.
Proximal tubule (PT) cells populated the most abundant clusters (clusters 10–16, Figure 3A). Cells from at
least 21 out of the 24 samples were found across 7 PT clusters, confirming broad contribution to the cellular clusters by the diverse samples (Supplemental Table 2). The top markers for cluster 10–16 were mitochondrial genes
(Figure 3B and Supplemental Table 1), suggestive of gradient differences in mitochondrial gene expression in
these 7 clusters (Supplemental Figure 1A). Increased mitochondrial activity in the PTs is well known (21). Moreover, single nucleus RNAseq (snRNAseq) studies, including those from KPMP on identical tumor-nephrectomy
tissues, have also reported more than the conventional PT cell types (S1, S2, and S3 cells) in their analyses (18, 19).
insight.jci.org   https://doi.org/10.1172/jci.insight.133267
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Figure 3. Unsupervised clustering of cells derived from adult kidney tissue. (A) UMAP plot from unsupervised clustering of 22,268 cells and number of
cells in each of the 31 clusters. (B) Expression levels of the top differentially expressed gene from each cluster across all clusters. Differential gene expression analyses, to identify cell type specific genes, were performed using the nonparametric Wilcoxon rank sum test. The cell type–specific genes with FDR
< 0.05 were considered as differentially expressed. UMAP, Uniform Manifold Approximation and Projection.

The cells of the distal nephron constituted the next-largest clusters, were identified based on known markers,
and included descending thin limb (DTL, cluster 31), ascending thin limb (ATL, cluster 29), thick ascending limb
(TAL, cluster 20) of the loop of Henle (LOH), distal convoluted tubule (DCT, cluster 21), connecting tubule
(CNT, cluster 22), and collecting duct cells (principal cells [PC], cluster 27; and intercalated cells [IC] A and B,
clusters 17 and 18, respectively). The Uniform Manifold Approximation and Projection (UMAP) dimensionality
reduction process of the expression data preserved the global structure (22) of the distal nephron (Figure 3A). In
addition to the major distal nephron cell types, we identified 3 cell clusters (clusters 19, 28, and 30) for which the
top differentially expressed genes suggested that the clusters consisted of potentially transitioning cell types.
The top differentially expressed genes in cluster 19 included known markers from principal (FXYD4)
and intercalated (ICA [SLC26A7] and ICB [SLC4A9]) collecting duct cells (Figure 5A). A similar cell
insight.jci.org   https://doi.org/10.1172/jci.insight.133267
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Table 1. Cluster cell type and number of cells
Cluster

Cluster name

Abbreviation

Number of cells

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31

Fibroblast
Podocyte
Myeloid cell
Myeloid cell
NK cells
Endothelial cell
Endothelial cell, peritubular
Glomerular capillary endothelial cell
Vascular smooth muscle cell and mesangial
Proximal tubule cell
Proximal tubule cell
Proximal tubule cell
Proximal tubule cell
Proximal tubule cell
Proximal tubule cell
Proximal tubule cell
Intercalated β cell
Intercalated α cell
Transitioning principal cell/intercalated cell
Thick ascending limb cell
Distal convoluted tubule cell
Connecting tubule
B cell
Cytotoxic T cell
T cell, activated
T cell, memory
Principal cell
Cortical connecting tubule principal cell
Ascending thin limb cell
Parietal epithelial cell/loop of Henle
Descending thin limb cell

FIB
POD
MYL1
MYL2
NKC
EC-AEA
EC-PT
GC-EC
vSMC/MC
PT-1
PT-2
PT-3
PT-4
PT-5
PT-6
PT-7
IC-B
IC-A
tPC-IC
TAL
DCT
CNT
B cell
T-CYT
T Cell
T-CYT-MEM
PC
PC-CNT
ATL
PEC
DTL

58
170
896
473
565
461
988
900
655
891
1212
987
813
891
1412
525
174
977
165
1343
901
451
141
1091
1095
898
1164
414
656
158
743
Total 22268 cells

Distribution of single cells isolated from tissue samples in 31 clusters and associated cell types.

cluster was previously reported and validated by a scRNAseq study in mice (14). This cluster had a
comparatively higher mRNA content (Supplemental Figure 1B).
Cluster 28, which we annotated to contain CNT-PC (cortical CNT IC) expressed known markers of
both PCs (FXYD4, STC1) and CNT cells (SLC8A1) (Supplemental Figure 1C), consistent with transitional
states between CNT to cortical collecting duct cells.
The cell type markers of cluster 30 included CTGF, CRB2, VCAM1, SLC4A11, and CLDN1 (Supplemental Table 1). Antibody staining of the coded proteins of those top genes referring to the
Human Protein Atlas (HPA; https://www.proteinatlas.org), showed that most of these markers were
expressed in glomerular parietal epithelial cells (PEC) and LOH cells. On examining this cluster
more closely, subclustering showed 2 clusters, subcluster 0 and 1, contained within cluster 30 (Figure 5B). The expression of WT1, CLDN1, and CRB2 in subcluster 0 suggests that this subcluster was
enriched for PEC, while the expression of TACSTD2 and SPP1 in subcluster 1 indicates enrichment
for LOH-derived cells.
Cluster 2 contains cells with known podocyte-specific markers, allowing the identification of potentially novel podocyte-specific transcripts (Figure 5C). Cluster 2 is composed of 170 cells identified as podocytes based on expression of known, podocyte-specific markers NPHS1, NPHS2, and PODXL. Podocytes
were identified in 19 out of the 24 tissue samples and constituted 0.75% of total cells. CRB2 was significantly overexpressed in podocytes compared with all other cell types. Additionally, CRB2 expression was
specific to clusters representing podocytes and PEC (Figure 5C).
insight.jci.org   https://doi.org/10.1172/jci.insight.133267
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Figure 4. UMAP plot showing the distribution of the single cells from the 24 samples used in the study. (A) UMAP plot showing the distribution of the
cells in the 31 clusters resulted from the unsupervised clustering of the scRNAseq data from tumor-nephrectomy, surveillance, and preperfusion biopsies.
(B) UMAP plot of the 14,744 cells from the 16 tumor-nephrectomy samples. (C) UMAP plot of the 4690 cells from the 5 surveillance transplant biopsy
samples. (D) UMAP plot of the 2834 cells from the 3 preperfusion biopsy samples.

Cluster 9 contained cells with known markers of smooth muscle cells, ACTA2, and TAGLN, consistent
with vascular smooth muscle cells and mesangial cells (VSMC/MC). The specific antibody staining of ITGA8
and SYNPO2 in the HPA authenticated the presence of MCs in this cluster (Supplemental Figure 2).
Multiple distinct immune cell types were observed in the scRNAseq data of the reference tissues.
Seven distinct immune clusters were identified: myeloid cells (clusters 3 and 4), NK cell (NKC) (cluster
5), B cell (cluster 23), cytotoxic T cell (T-CYT) (cluster 24), activated T cell (T-ACT) (cluster 25), and
T memory cell (T-MEM) (cluster 26).
Cluster 1 — the smallest cluster, comprising only 58 cells — was identified as a fibroblast cluster
based on its top markers, including decorin (DCN), collagen type 1 α 2 (COL1A2), and lumican (LMN).
Based on the known endothelial marker CD34, three endothelial clusters were identified (clusters
6, 7, and 8); specific markers for these 3 clusters include SERPINE2 (cluster 6), PLVAP (cluster 7),
and EHD3 (cluster 8) (Figure 3B). These 3 endothelial clusters were the focus of further evaluation of
underlying biological processes and their relationship to disease progression.
insight.jci.org   https://doi.org/10.1172/jci.insight.133267
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Figure 5. Cell type markers of clusters 19 and 30. (A) Violin plots of PC and IC cell markers: FXYD4 expression in PC (cluster 27); SLC26A7 in ICA
cells (cluster 18); SLC4A9 in ICB (cluster 17); and all 3 in transitional PC-IC cells (cluster 19). (B) tSNE plot of the 2 subclusters of cluster 30; dot plot
of relative expression levels and HPA antibody staining of parietal endothelial cells (CRB2, CLDN1, and WT1 in subcluster 0) and LOH cell markers
(SPP1, TACSTD2, and SLC128A1 in subcluster 1). (C) Violin plot shows the specific NPHS2 expression in cluster 2 (podocytes). HPA antibody staining
of NPHS2 confirms its specific expression in podocytes. Violin plot of CRB2 expression shows that this gene is expressed in clusters 2 and 30. HPA
antibody staining of CRB2 shows that it is expressed in podocytes and parietal epithelial cells. The HPA antibody stainings are from normal human
kidneys, and figures indicate scale of 20 μm; additional details in Supplemental Figure 6). PC, principal cells; IC, intercalated; PEC, parietal epithelial
cells; LOH, Loop of Henle; HPA, Human Protein Atlas.

insight.jci.org   https://doi.org/10.1172/jci.insight.133267
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Figure 6. Validation of cell cluster assignment. (A) Heatmap of correlation between the average expression of genes in cell
types identified in human developing kidney and adult kidney scRNASeq data (columns, developing kidney; rows, adult kidney). (B) Heatmap showing correlation between the average expression of genes in cell types identified in scRNAseq (rows)
and snRNASeq (columns) analyses. Row-wise Z-score scaling of gene expression was used for heatmap visualization.

Comparative assessment of adult kidney single cell data. We used independently generated kidney single
cell or single nucleus datasets to assess the cell type distribution and coverage of the scRNAseq data
from adult kidney tissue samples. To compare the average gene expression of genes in major cell types
identified in published developing kidney tissue data (10) with that of the cell types in our adult kidney
scRNAseq data, heatmaps using Pearson’s correlation values were generated. Positive correlation of
average expression levels between the corresponding cell types in the 2 data sets — especially between
the podocytes, distal tubular, collecting duct, endothelial, stromal, and immune cells — were observed
(Figure 6A). In addition, we similarly compared our data with published adult human kidney snRNAseq dataset (19). Average transcript expression of the major cell types in the 2 data sets had correlation
values greater than 0.7 (Figure 6B).
Validation of endothelial cell types. Unlike bulk mRNA analysis, the single cell technology was successful in characterizing multiple endothelial cell clusters. Confirming the distinct cellular identities of these
clusters, we demonstrated the expression of 1 distinct marker for each of the 3 endothelial cell clusters,
clusters 6–8 (Figure 7A), using in situ hybridization (ISH; Figure 7B). As predicted from the scRNAseq
analysis, the ISH signal for SOST was found to be specific to glomerular endothelial cells (GECs) (cluster
6); PLVAP probes hybridized to peritubular capillary endothelial cells (cluster 7) and SERPINE2 were
specifically expressed in arteriolar endothelial cells (cluster 8). We were also able to validate these findings by clustering mouse kidney scRNAseq data available at NCBI, Gene Expression Omnibus (GEO)
dataset (GSE107585) (14) and identifying 3 similar endothelial cell subclusters (Figure 7C). Furthermore, the top markers in the 3 human kidney endothelial clusters also marked peritubular capillary endothelial, glomerular endothelial, and arteriolar endothelial cells in murine scRNAseq data (Figure 7D).
insight.jci.org   https://doi.org/10.1172/jci.insight.133267
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Figure 7. Endothelial cell types. (A) Violin plots with cluster-specific
expression of SERPINE2 in arteriolar endothelial cells (cluster 6),
PLVAP in peritubular endothelial cells (cluster 7), and EHD3 in glomerular endothelial cells (cluster 8). (B) Validation using ISH for the specific expression of SOST, PLVAP, and SERPINE2 in glomerular endothelial, peritubular capillary endothelial, and arteriolar endothelial
cells, respectively. SERPINE2 and SOST images have magnification
of 400×. Scale bars: 20 μm. The PVLAP image has magnification of
200×. Scale bar: 50 μm. (C) UMAP plot showing the clusters from the
integrated analysis of human and mouse endothelial cells. Unsupervised clustering using Seurat R package at a resolution of 0.1 resulted
in 3 distinct clusters. Cells from both human and mouse scRNAseq
data were found in the 3 clusters. (D) Heatmap of the top 5 markers
for each of the 3 clusters from the integrated analysis of human and
mouse endothelial cells. Differential gene expression analyses, to
identify cell type–specific genes, were performed using the nonparametric Wilcoxon rank sum test. The cell type–specific genes that
were differentially expressed with FDR < 0.05 were considered.

insight.jci.org   https://doi.org/10.1172/jci.insight.133267
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Integrative analysis of single cell endothelial marker with bulk mRNA identifies a distinct FSGS subgroup
with activated GECs. Endothelial dysfunction has been shown to contribute to the development and progression of kidney diseases (23). Focusing on the 3 endothelial cell clusters in our data (Figure 8A), we
identified 26 genes selectively expressed in all 3 endothelial clusters and 78 genes specific to GECs (Figure 8A, yellow). The set of GEC-specific genes were used to derive an aggregate GEC score to extract
the differential regulation of these transcripts in bulk kidney biopsy transcriptomic data sets. The GEC
scores were determined for the glomerular transcripts across 10 glomerular kidney diseases studied in
the European Renal cDNA Bank (ERCB, Figure 8B) and the NEPTUNE (Figure 8C) cohorts. In both
cohorts, the highest average and median GEC scores were observed in patients with focal segmental
glomerulosclerosis (FSGS), and GEC scores were significantly higher in glomerular disease samples
compared with biopsies from living kidney donors (P < 0.005) (Figure 8, B and C). Interestingly, FSGS
patients with exposure to immunosuppressive treatment showed significantly lower GEC scores compared with treatment naive patients at time of biopsy, consistent with an acute inflammatory nature of
the endothelial score signature (Figure 8C). Given the functional heterogeneity of patients with FSGS,
we evaluated the GEC transcripts for their ability to distinguish groups within FSGS using bulk RNAseq
profiles available from NEPTUNE. Two distinct clusters (Figure 9A), group 1 (40 patients; median GEC
score, –0.26) and group 2 (28 patients; median GEC score, 0.37) were identified. In a genome-wide comparison, we found 3745 genes significantly differentially expressed (FDR < 0.05) between group 1 and
group 2 (top 100 differentially expressed genes shown in Supplemental Table 3).
For the top 100 overexpressed genes between groups 1 and 2, we were able to identify 3 significant
kidney-specific functional modules: Angiogenesis, extracellular matrix, and cell cycle (Figure 9B). An
interaction network generated using STRING (24) for the same top 100 genes is shown in Figure 9C. This
network included direct interactions between the top endothelial markers, including NRP1, TEK, and
KDR, with FN1, a known marker implicated in glomerulosclerosis. Additionally, extracellular matrix–
and mitotic cycle–associated proteins were enriched in the interaction network (Figure 9C).
We used weighted gene coexpression network analysis (WGCNA), which identifies coexpression modules that encapsulate the correlation patterns among genes across samples in order to further elucidate the
functional context of the endothelial network contained in the 2 FSGS groups. The top 2 gene set modules that significantly correlated with the groups (1 and 2) and GEC scores (for each sample) were brown
module, with 517 genes positively correlated with the GEC score and the groups, whereas a blue module
with 1106 genes negatively correlated with these traits (Supplemental Figure 3A). The positively correlated
genes were enriched for Gene Ontology (GO) biological processes, including glomerulus vasculature, Ras
protein signaling, and type 1 IFN response. The negatively correlated genes were mainly enriched for the
TGF-β signaling pathway (Supplemental Figure 3A). WGCNA using just patient data with no immunosuppressive treatment exposure at time of biopsy from group 1 and group 2 showed the enrichment of similar
biological processes (Supplemental Figure 3B).
We then examined predicted upstream regulators of the genes differentially expressed between
group 1 and group 2. Evaluating enrichment and direction of differential gene expression changes
using known cause-and-effect relationships, the top upstream regulators were predicted using Ingenuity Pathway Analysis (IPA). A positive activation score indicates that the upstream regulator was activated for the observed differential gene expression pattern. STAT1 and VEGF were the top 2 upstream
regulators with high activation scores (Figure 9D).
The mechanistic network of both STAT1 and VEGFA shown in Figure 9E identified A2M as a relevant downstream target gene. A2M was also the top differentially expressed gene in FSGS samples when
comparing group 2 with group 1, based on log counts per million (log cpm) and log fold change (logFC).
To summarize, from this multilevel integrative analysis, we identified 2 subgroups of FSGS patients
with distinct molecular expression patterns differentiated by the expression of GEC genes. Multiple lines
of evidence implicated A2M as a downstream target differentially regulated in those FSGS subgroups.
Intrarenal A2M mRNA expression associates with FSGS disease progression. Figure 10A shows the average mRNA expression of A2M in the 2 groups identified based on GEC scores among FSGS participants in NEPTUNE. Significantly higher A2M expression is observed in group 2 compared with group
1. A2M IHC in normal human kidney tissue in HPA indicates robust glomerular protein staining in a
pattern following the mRNA expression (Figure 10B). In scRNAseq A2M expression was found in the
3 endothelial cell subtypes and VSMC/MCs in adult human kidney (Figure 10C). A2M ISH in sections
insight.jci.org   https://doi.org/10.1172/jci.insight.133267
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Figure 8. Analysis of glomerular
endothelial marker genes. (A) Venn
diagram intersect of endothelial-specific
clusters from scRNAseq data highlighted
30 genes specific to all 3 endothelial
clusters. (B and C) Glomerular endothelial
cell (GEC) scores, derived based on 78
genes selective for glomerular endothelial cells (yellow), were calculated for
patients and compared across the kidney
disease spectrum in the European renal
cDNA bank cohort (ERCB) (B) and the
NEPTUNE cohort (C). GEC scores were
elevated in disease groups compared
with those of living donors. The GEC
scores in FSGS patients with exposure
to immunosuppressants prior to time of
biopsy was substantially lower compared
with those with no prior exposure. AAV,
ANCA-associated vasculitis; DN, diabetic
nephropathy; FSGS, focal segmental
glomerulosclerosis; HTN, hypertensive
nephropathy; IgAN, IgA nephropathy;
MCD, minimal change disease; MN-MGN,
membranous glomerulonephritis; SLE,
systemic lupus erythematosus; TMD,
thin basement membrane disease; LD,
living donor; TNx, unaffected parts of
tumor-nephrectomy.

from reference and FSGS kidney tissue showed a pattern consistent with the endothelial and mesangial
scRNAseq expression (Figure 10D). Replicating the NEPTUNE results, higher expression levels of
A2M transcripts were observed in samples from patients with FSGS and diabetic nephropathy (DN) in
the ERCB cohort compared with living donors (Figure 11A and Table 2). Finally, high A2M mRNA
expression at the time of initial biopsy were associated with poor prognosis, as evidenced by the longer
time to reach complete remission of proteinuria in NEPTUNE study participants (Figure 11B).

Discussion
We successfully generated a reference kidney single cell expression atlas with 22,268 cells derived from
31 distinct kidney cell types. The cell clusters covered the entire spectrum of kidney cell types found
insight.jci.org   https://doi.org/10.1172/jci.insight.133267
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Figure 9. Integrated analysis of scRNAseq and bulk mRNAseq data. (A) Two distinct groups from the hierarchical clustering of the 78 glomerular endothelial cell defining mRNA transcripts in isolated glomeruli of FSGS biopsy samples from the NEPTUNE cohort. (B) Kidney-specific functional module gene
interaction network (https://hb.flatironinstitute.org). The figure shows the 3 significant functional modules and their interactions. (C) Protein interaction
network generated using STRING for the top 100 genes that were substantially overexpressed in group 2 versus group 1. (D) Top upstream regulators predicted by IPA. The bar plots show the activation scores predicted by IPA for the top 5 upstream regulators (P < 0.05 by Fisher’s exact test). (E) The regulatory
interaction of the top 2 regulators, VEGF growth factor, and STAT1 show A2M as a downstream target. FSGS, focal segmental glomerulosclerosis.

along the nephron, as well as resident immune cells. Clustering of the single cell data from a single
sample type may miss a rare cell type, like podocytes, due to lack of power based on number of cells.
However, the combined analysis of the 22,268 cells enabled the detection of a distinct podocyte cell
cluster. Additionally, generating single cell transcriptomics data from adult human kidney tissue can
be challenging due to the rapid decline of cell viability upon tissue dissociation (17). In this study, we
were able to analyze single cell transcriptomic data from 16 tumor-nephrectomies, 5 surveillance biopsies derived from transplant patients with normal kidney function and histology, and 3 preperfusion
living donor biopsy samples and assign cells to distinct clusters without significant confounders due
to the tissue source. Furthermore, by integrating the cell type–specific information of GECs with bulk
insight.jci.org   https://doi.org/10.1172/jci.insight.133267
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Figure 10. α-2-Macroglobulin
(A2M) expression. (A) Box plot
showing average glomerular
RNAseq read count of A2M
transcripts in samples from the
GEC group 1 and group 2. (B)
Human Protein Atlas antibody
staining of A2M in normal
human kidney. Scale bar: 50
μm. (Supplemental Figure 6
contains specific information on
HPA immunostaining of A2M).
(C) Violin plot showing the cell
type scRNAseq expression of
A2M transcripts in adult human
kidney. (D) In situ hybridization
fluorescence images showing
the glomerular signal of A2M
probes in 2 unaffected parts of
tumor-nephrectomy (left panel)
and FSGS (right panel) kidney
tissue sections. Glomeruli are
encircled by thin white lines.
The images are at 200× magnification. Scale bar: 50 μm.

mRNA data, we were able to identify 2 distinct groups of FSGS patients, with GEC activation being
most prominent in immunosuppressive naive patients.
The need to generate single cell suspensions from complex tissues can introduce a selection bias
by the isolation procedure. In KPMP parallel strategies of cell-level analyses are pursued and allow
direct comparison between the different technologies. Comparison of our kidney single cell data with
published single nucleus data (19) show a significant overlap with robust cell-to-cell correlation but
also are complementary, with certain cell types more enriched in one compared with the other technology. For example, enrichment of immune cells is observed in scRNAseq compared with snRNAseq,
insight.jci.org   https://doi.org/10.1172/jci.insight.133267
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Figure 11. A2M expression in FSGS. (A) Box plot showing the expression of A2M mRNA in different kidney diseases in ERCB cohort: DN, FSGS, MCD, MN, LD. (D) Kaplan-Meier curves by A2M mRNA expression levels at baseline
biopsy for the first complete remission event in NEPTUNE FSGS patients. Two-sided Student’s t test showed that
high A2M mRNA expression at the time of initial biopsy was associated with poor prognosis, as evidenced by the
longer time to reach complete remission of proteinuria in NEPTUNE study participants (P < 0.02). DN, diabetic nephropathy; FSGS, focal segmental glomerulosclerosis; MCD, minimal change disease; MN, membranous
nephropathy; and LD, living donor.

providing a strong rationale to study the adult human kidney at the single cell level for a thorough
understanding of the kidney transcriptome.
One of the key features in our study is the integration of the single cell data, with glomerular
mRNA biopsy gene expression data dissecting the contribution of specific cell types to the disease state.
In this study, we focused on endothelial cell phenotypes in the kidney, given their known involvement,
and the limited mechanistic elucidation of their role in human glomerular disease pathophyisiology,
thus far. We observed 3 distinct endothelial cell types across all 3 reference tissue sources and confirmed
the same cluster pattern by reanalyzing a published murine study (14, 25) with the recent study of
murine kidney by Dumas et al., showing extensive renal endothelial cell phenotypic heterogeneity (25).
The scRNAseq endothelial subtype–specific gene sets enabled the development of a GEC score. The
GEC score was subsequently applied to bulk gene expression data sets from microdissected glomeruli
(Glom) obtained from patients with a wide spectrum of glomerular diseases. We not only could observe differential regulation of the GEC markers across diseases, but we could also identify 2 subgroups of patients
with activation of the GEC-specific genes in FSGS, a disease known for its substantial heterogeneity in
disease initiation, treatment responsiveness, and rates of progression (26, 27).
In the FSGS patient kidney biopsies, known endothelial marker genes NRP1, KDR, and TEK,
encoding the receptors for growth factor ligands including VEGFA, VEGFD, ANGPT1, and ANGPT2,
insight.jci.org   https://doi.org/10.1172/jci.insight.133267
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Table 2. A2M expression in different kidney diseases in the ERCB cohort
ANOVA results

Group
P value
F value

A2M
0.006
7.714

LD
DN
MCD

FSGS

MN

MCD

DN

6 × 10
0.83
0.4

0.05
0.02
0.99

0.04
0.11
NA

0
NA
0.1

–7

Two-way ANOVA indicates significant difference (P < 0.001) in A2M transcript levels in FSGS and DN patients compared with LD. DN, diabetic nephropathy;
FSGS, focal segmental glomerulosclerosis; MCD, minimal change disease; MN, membranous nephropathy; and LD, living donor.

were overexpressed in FSGS group 2 compared with group 1 (Supplemental Figure 4). The single cell
analysis enabled us to identify the cell type–specific expression of these ligands and receptors. Supplemental Figure 4A illustrates the potential cell-to-cell interactions between the endothelial cells and
podocytes, fibroblast, and MCs.
The endothelial cell–driven gene signatures juxtapose patients with an inflammatory GEC activation state from those with profibrotic glomerular transcriptional signatures (28). The 2 FSGS groups
were characterized by distinct expression signatures with group-specific functional enrichments. Both kidney-specific functional module analysis and the STRING interaction network illustrated similar functional
enrichments. Extracellular matrix functional processes, endothelial development, and cell division were
significantly enriched for the genes that were overexpressed between group 2 and group 1. The functional
enrichment of the genes in the WGCNA module showed glomerular vasculature development, type 1 IFN,
and RAS protein signaling pathways as enriched in group 2 compared with group 1 (Supplemental Figure
3A). TGF-β signaling response genes, which have an established profibrotic role in FSGS pathology, were
higher in group 1 compared with group 2 (29).
The enrichment of type 1 IFN signaling in group 2 compared with group 1 and the identification of
STAT1 as the top upstream regulator for the differentially expressed genes in this group is consistent with
established STAT1 activation by IFNs (30, 31). Tao et al. have described activation of the JAK/STAT
signaling pathway in FSGS in the NEPTUNE cohort (32), with higher STAT1 transcriptional activity
scores and elevated levels of phosphorylated STAT1 in glomerular and tubular compartments from FSGS
patients. Together, these findings suggest that type 1 IFN–mediated STAT1 activation could be a key mechanism involved in glomerular disease progression for group 2 patients with endothelial cell activation. In
a phase II clinical trial for patients with diabetic kidney disease, treatment with a JAK/JAK2 inhibitor
resulted in a reduction in albuminuria (4) and was well tolerated, suggesting that this mechanism may also
be amenable to therapeutic intervention in patients with FSGS. Intriguingly, the GEC score was highest in
immunosuppressive treatment–naive NEPTUNE participants and significantly lower in patients with steroid and/or second-line immunosuppression at time of biopsy (Figure 8C). This argues not only for a high
inflammatory state of the endothelium in a substantial subset of untreated FSGS patients (Supplemental
Figure 3B), but it is also consistent with the ability of immunosuppressive treatments to rapidly impact the
GEC activation in FSGS. Crosstalk between endothelial cells with MCs and podocytes supports a highly
dynamic role of the glomerular endothelium in FSGS (Supplemental Figure 4).
Analysis of the differences in the gene expression of the 2 GEC-defined groups pointed to A2M as a downstream mediator linked to the FSGS heterogeneity. Upstream regulator analysis predicted A2M as a target
gene of STAT1. This observation is further supported by Satoh and Tabunoki (33), who identified A2M as a
target gene for the STAT1 transcription factor in their ChIP-seq analysis. A2M protein is a known marker of
glomerular permselectivity, a property of the glomerular capillary wall that serves to exclude macromolecules
from the urinary space. The ratio of urine A2M protein to albumin has been reported as a predictor of steroid
response since as early as 1964 (34), with filtered A2M in the urine as an indicator of severe loss of glomerular
permselectivity. The limited immunohistochemical staining of A2M in kidney biopsies have, thus far, been
viewed as systemic and incidental to loss of glomerular permselectivity, rather than the consequence of intrarenal A2M synthesis (35). Our mRNA gene expression data sets from scRNAseq, microdissected glomerular
RNAseq, and ISH argue for an intrinsic intrarenal regulation of A2M in glomerular disease (Figure 10D).
A2M is a nonspecific protease inhibitor able to impact the function of a wide range of proteins (36). Relevant
in a glomerular context is the ability of A2M to inhibit matrix-degrading proteases, including MMPs (37). Inhibition of MMP is one mechanism leading to the glomerular matrix accumulation characteristic of FSGS. The
insight.jci.org   https://doi.org/10.1172/jci.insight.133267
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STRING protein interaction and kidney-specific functional module analyses in the glomerular NEPTUNE
data sets indicate a close link between A2M and glomerular matrix changes in the FSGS population studied.
Podocyte injury is the earliest observed morphological feature of FSGS (26, 38). A2M is an effective
inhibitor of activated protein C (aPC) (39), with recent data indicating aPC as protective against apoptosis
of podocytes in DN (40). Thus, inhibition of aPC by A2M may block the protective role of aPC. In addition, repression of aPC is known to enhance thrombin generation (41), and Kerlin and colleagues recently
have shown that thrombin injures podocytes (42). A2M-mediated inhibition of aPC-mediated podocyte
protection may simultaneously enhance thrombin-mediated podocyte injury.
There are several limitations to be considered with the described study. Multiple tissue sources were
used to represent the normal tissue state of the kidney. While each of these sources has its specific limitations, contribution of all 3 tissue sources to the cellular clusters identified argues for the robustness
of the cellular differentiation reported.
One intrinsic limitation of single cell studies is the need to generate single cell suspension, which may
cause selective loss of some cell populations (17). For example, podocytes are highly sensitive to tissue
dissociation processes. However, the proportion of podocytes recovered by our protocol was aligned with
the abundance of these cells in adult kidneys reported by others (20, 43). The resolution used in the unsupervised clustering step could have resulted in the overclustering of proximal cells to 7 clusters rather than
to the known 3 segments, namely S1, S2, and S3. However, a lower resolution would have missed the identification of other major kidney cell types. Comparison with the snRNAseq data indicates a good overall
agreement between clusters and cluster-associated transcripts. Further studies to systematically compare
and integrate the different single cell technologies on the same adult human tissue are ongoing in KPMP.
Another caveat of this study is the impact of tissue dissociation at 37°C. Our initial bulk mRNA analysis on
pre- and postdissociation kidney tissue indicated no effect; however, more detailed analysis is warranted to
rule out the impact of tissue dissociation at 37°C (Supplemental Figure 5, A–C).
In this study, we generated a comprehensive single cell transcriptome of the adult human kidney and
identified known and potentially novel cell type–specific markers, along with transient cell types between
renal segments. Our scRNAseq-driven endothelial cell characterization in FSGS Glom revealed potentially novel molecular heterogeneity within patients with FSGS. We identified 2 distinct FSGS groups with
significant differences in the intrarenal A2M gene expression levels. The group with the higher A2M gene
expression associated with poor prognosis. As molecular pathways linked to FSGS are targeted by several
emerging therapeutics, this integrative analysis provides avenues for investigation whereby not only insights
into differences in normal and diseased adult human kidneys can be gathered, but such explorations can
also serve as frameworks for precision medicine in order to identify the appropriate drug for a specific
patient diagnosed with a glomerular disease.

Methods
Human samples. For generating the single cell transcriptome, we processed 24 CryoStor preserved human
kidney samples: 16 tumor-nephrectomy, 5 human allograft kidney transplant surveillance, and 3 preperfusion transplant biopsy samples. Ten of the 16 tumor-nephrectomy samples were processed at the Broad
Institute, and all the remaining samples were processed at the University of Michigan. The surveillance
biopsies were obtained from patients at 3–6 months after transplant; all 5 biopsy samples were confirmed
as histologically normal. Additionally, 3 preperfusion biopsies procured from donor kidneys before transplant were used as most representative of normal kidney tissue. Only small quantities (2–3 mg) of the
biopsy samples were used for the scRNAseq procedure.
As part of the Accelerating Medicines Partnerships lupus network Pathway Exploration and Analysis in Renal disease (AMP-PEARL) network, we have developed and optimized protocols for kidney
biopsy sample acquisition in distributed research networks for dissociation of single cell suspension and
subsequent RNAseq studies (15). We modified the protocol published by the AMP-PEARL network to
increase kidney epithelial cell yield. Briefly, kidney biospecimen were placed in 1 mL HypoThermosol
(Stemcell Technologies) and immediately transferred to the laboratory and cryopreserved in DMSO containing CryoStor CS 10 (Stemcell Technologies) solution for long-term storage in liquid nitrogen (Figure 1).
Single cell isolation. For tissue dissociation, samples were quickly thawed in a 37°C water bath for 1
minute, transferred to a small dish containing 1 mL DMEM/F12 medium (with L-Glutamine, HEPES,
and high glucose) supplemented with 10% heat-inactivated FBS, and incubated for 10 minutes at room
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temperature. Tissue/biopsy samples were cut into 1-mm3 pieces to increase the surface area before they
were transferred to a 1.5-mL tube containing 500 μL DMEM/F12 digestion media, which contained 125
ng Liberase TL (MilliporeSigma) enzyme. Samples were incubated on an orbital shaker (500 rpm) for 12
minutes at 37°C with a mild trituration step using a wide-bore 1000 μL tip applied after 6 minutes. Digestion was stopped by adding 500 μL DMEM/F12 medium containing 10% FBS and incubated at room
temperature for 1 minute. The cell suspension was then filtered through a 30-μm strainer (Milteny Biotec)
into a 15-mL conical tube. Remaining solid tissue was passed through the nylon mesh using the rubber end
of a 3-mL syringe pestle, and the filter was washed with 10-mL DMEM/F12/10%FBS medium. Cells were
pelleted by centrifugation for 10 minutes at 200 g at 4°C. The supernatant was immediately, completely
removed by vacuum suction using a glass Pasteur pipet. The cell pellet was then gently resuspended in 55
μL DMEM/F12/10%FBS medium, and cell viability was analyzed with a Countess II FL automated cell
counter exploiting the trypan blue dye exclusion method.
10× Genomics and Next Generation Sequencing (NGS) of single cell mRNA. Single cell samples were immediately transferred to the University of Michigan Sequencing Core facility. About 10,000 viable cells in up
to 46 μL DMEM/F12/10%FBS per sample were added to each channel of a chip on the droplet-based
high-throughput 10× Genomics Chromium platform allowing cell lysis, individual cell barcoding, and
reverse RNA transcription. We used the 10× Single Cell 3’ GEX – version 2 chemistry for all tumor-nephrectomy samples and the enhanced 10× Single Cell 3’ GEX – version 3.1 for the more recently processed transplant surveillance biopsies and preperfusion biopsies. Single cell library preparation was executed by the core facility and included emulsion breakage, PCR amplification, cDNA fragmentation, oligo
adapter, and Illumina sample index addition. Libraries have been pooled and sequenced on an Illumina
HiSeq4000 platform as asymmetric paired end runs (26 × 115 bases) with a median of 100 million raw
sequencing reads per sample. The output from the sequencer was first processed by CellRanger, the proprietary 10× Chromium single cell gene expression analysis software (https://support.10xgenomics.com/
single-cell-gene-expression/software/pipelines/latest/what-is-cell-ranger).
Tissue dissociation effect analysis. To account for the potential for genes to be induced during tissue dissociation using Liberase TL at 37°C, we compared bulk gene expression RNAseq data before and after cell
dissociation for 4 tumor-nephrectomy samples (Supplemental Figure 5A). We found a stringent correlation
between pre- and postdissociation gene expression for each of the 4 samples (Supplemental Figures 5, B
and C). Pre- and postdissociation bulk mRNA analysis show that the short duration of 12 minutes of dissociation using Liberase TL did not have a significant impact downstream biological processes.
Data analysis of single cell data. Data analyses were performed on the CellRanger output data files
using Seurat 3 R package (https://cran.r-project.org/web/packages/Seurat/index.html). As a quality
control step, cells with less than 500 genes per cell were filtered out. The percentage of mitochondrial
gene read content has emerged as a quality measure for the cell viability in single cell studies. A high
percentage of mitochondrial reads indicate that the cells are less viable, indicative of cytoplasmic mRNA
loss due to the degradation of plasma membrane during the dissociation process. For the tumor-nephrectomy data generated applying the Chromium Next GEM Single Cell 3′ GEM, Library & Gel Bead
Kit version 2, a threshold of < 20% mitochondrial reads per cell was used, whereas a cutoff of < 50%
mitochondrial reads per cell was applied for the data from the version 3 kit. It has been observed by us
and other groups that, for certain tissues, including kidney, 10× Genomics version 3 chemistry results
in a higher percentage of mitochondrial reads, irrespective of the viability status of the cells. This issue
was circumvented by deeper sequencing of the samples (200 million reads) to obtain more genes per cell.
After the quality control step, the data from the 3 sample types (tumor-nephrectomy, surveillance biopsy,
and preperfusion biopsy) were merged and further analyzed. Doublet formation is a concern in single
cell technology, where 2 cell types in close proximity can be engulfed by a single droplet. The mRNA
content and number of genes of doublets are comparatively higher than mRNA content and number
of genes of single cells. In order to reduce doublets or multiplets from the analysis, we used a cutoff of
> 500 and < 5000 genes per cell. However, in certain cell types (for example, in the cells transitioning
between 2 cell types), the mRNA content can be higher than other cell types (cluster 19, in this study).
The downstream analysis steps included SCTransform, dimensionality reduction principal component analysis (PCA) and UMAP (44), standard unsupervised clustering, and the discovery of differentially
expressed cell type–specific markers (45). We used the SCTransform functionality embedded in Seurat R
package for normalization and scaling of UMI and mitochondrial content. In addition, we included the
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batch information as a variable in the SCTransform to scale out the differences between the batches. For the
unsupervised clustering, we chose 1.75 as the resolution parameter. Differential gene expression analyses, to
identify cell type–specific genes, were performed using the nonparametric Wilcoxon rank sum test. Harmony, a R package, was used to integrate single cell datasets before the unsupervised clustering (46).
For cell type annotation, we used publicly available resources, including Kidney Interactive Transcriptome (http://humphreyslab.com/SingleCell/), HPA (https://www.proteinatlas.org), the Epithelial Systems Biology Laboratory (ESBL) (https://hpcwebapps.cit.nih.gov/ESBL/Database/), scRNAseq data
(19), and Immgen (https://www.immgen.org/).
Bulk mRNA profiling from patients with kidney disease. Total RNA was isolated from microdissected kidney Glom of biopsy samples from the ERCB cohort and from the NEPTUNE cohort using well-established protocols that demonstrate enrichment for abundance of glomerular mRNAs (47, 48). Microarray
profiles were generated on glomerular samples as previously described (49) and were deposited into GEO
under accession numbers GSE104948 (ERCB) and GSE104066 (NEPTUNE). Bulk glomerular RNAseq
expression data were obtained for 74 participants with biopsy-proven FSGS enrolled in the NEPTUNE
study. Briefly, mRNA samples were prepared using the Illumina TruSeq mRNA Sample Prep v2 kit. Multiplex amplification was used to prepare cDNA with a paired-end read length of 100 bases using an Illumina
HiSeq2000. RNAseq was performed by the University of Michigan Advanced Genomics Core (https://
brcf.medicine.umich.edu/cores/advanced-genomics/). Quality of the sequencing data was assessed using
the FastQC tool (http://www.bioinformatics.babraham.ac.uk/projects/fastqc/). Read counts were extracted from the fastq files using HTSeq (version 0.11). The objectives and study design of NEPTUNE can be
found in the clinicaltrials.gov database under NCT1209000 (50).
Development of the GEC transcription score. Aggregate GEC scores were generated in samples profiled on
microarrays from patients across the kidney disease spectrum who were part of the ERCB and NEPTUNE
cohorts. We established a glomerular GEC score from 78 glomerular endothelial marker genes identified
from single cell data using previously described methods (12, 49). Genes expressed on glomerular microarray profiles from ERCB (60 of 78 genes) and NEPTUNE (77 of 78 genes) were Z-transformed; then, the
average Z-score per disease group was used for comparison among diseases.
WGCNA of bulk mRNA data. Gene set modules were generated by WGCNA (51) of the top 5000
variable genes between the groups 1 and 2 identified through hierarchical clustering of bulk mRNA
expression profiles of the 74 FSGS patients. Enriched GO biological processes were identified for the
coexpressed gene sets.
Kidney-specific functional modules. Module detection was performed using a kidney tissue–specific gene
functional network (52, 53). We consider the subgraph of the kidney-specific network consisting of the top
100 genes significantly overexpressed in group 2 FSGS patients relative to group 1 FSGS patients, as well as
all edges between them. Four of the top genes were not present in the kidney-specific functional network,
leaving a network of 96 genes. For each pair of these genes, we then counted the number of shared neighbors among the top k edges in the subgraph incident to each gene, and we chose the 5% of pairs with the
most shared neighbors as edges in a shared k-nearest neighbors (sKNN) graph. (Here, k is set to 20% of
the number of genes). We then performed community clustering using the Louvain algorithm to identify
modules in the sKNN graph. Community clustering was repeated 100 times, and a comembership score
was computed for each pair of genes. The comembership score was equal to the fraction of runs in which
the gene pair was assigned to the same module. To produce output modules, community clustering was
performed on the graph with edges between each pair of genes with a comembership score of at least 90%.
Validation of endothelial cell types using ISH. In situ detection of sclerostin (SOST, RNAscope probe_Hs-SOST,
Advanced Cell Diagnostics [ACD], catalog 452941), plasmalemma vesicle associated protein (PVLAP, RNAscope probe_Hs-PLVAP, ACD, catalog 437461), serpin family E member 2 (SERPINE2, RNAscope probe_
Hs-SERPINE2, ACD, catalog 412661) and α-2-macroglobulin (A2M, RNAscope probe_Hs-A2M-C2, ACD,
catalog 532501-C2) mRNA transcripts using the RNAscope kit (Advanced Cell Diagnostics) were performed
according to the manufacturer’s protocol by kidney pathologists able to identify cell types in kidney tissue. Sections (3 μm) sections of deidentified human kidney tissue were cut from formalin-fixed, paraffin-embedded
(FFPE) blocks supplied by the University of Michigan Tissue Procurement Service. Housekeeping gene peptidylprolyl isomerase B (PPIB) was used as an internal, mRNA control; if the PPIB score was 0, the sample
was regarded as not available for gene expression. A horseradish peroxidase–based signal amplification system
(RNAscope 2.0 HD Detection Kit-Brown, ACD, catalog 310035) was used for hybridization to the target probes,
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followed by color development with DAB, and the slides were counter-stained with hematoxylin (RICCA chemical company, catalog 3535-16). Positive staining was determined by brown punctate dots in the cytoplasm.
Data sharing. The gene matrix files from the scRNAseq data and the raw read counts from the bulk
mRNA data used in the above analyses are uploaded to NCBI GEO database under accession number
GSE140989. Data can also be viewed at http://nephrocell.miktmc.org. The single cell data are also available at the KPMP Atlas data repository (https://atlas.kpmp.org/repository).
Statistics. The workflow of our integrative analysis of single cell and bulk mRNA is described in Figure
1. EdgeR R package (54) was used for genome-wide differential gene expression analysis between the FSGS
subgroups resulting from the hierarchical clustering of GEC type gene expression. Model-based normalization function embedded in the edgeR adjusted for the sequencing depth and RNA composition differences
between the samples. Next, an empirical Bayes strategy for squeezing the tagwise dispersions toward a
global dispersion trend or toward a common dispersion value was applied. After negative binomial models
were fitted and dispersion estimates were obtained, testing procedures for determining differential expression using the exact test was performed. We considered only the genes that were differentially expressed
with an adjusted P < 0.05 (54). Association between the significantly differentially expressed genes with
clinical parameters, including time to complete remission of proteinuria, were performed using STATA,
v12.1 with 2-tailed Student’s t tests of hypotheses and P < 0.05 as the criterion for statistical significance.
Comparison of upstream regulators related to differentially regulated genes were explored using IPA Software Suite (https://www.qiagenbioinformatics.com/products/ingenuity-pathway-analysis/).
Study approval. All samples used in this study were obtained with patient consent and with the approval of
IRBs of participating institutions, described below. The KPMP study is reviewed and approved through central IRB process at The Human Research Protection Office and Washington University in St. Louis (IRB no.
201902013). Transplant biopsies were obtained after review and approval of the Transplant Transcriptomic
Atlas study, HUM00150968, by the University of Michigan IRBMED. NEPTUNE data were obtained based
on the multisite, central IRB approval for the study, HUM00158219, by the University of Michigan IRBMED.
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